Stellate Hypopigmentation in a Pediatric Patient After Treatment with Intralesionally-Injected Corticosteroid

Janet E. Lubov; Craig A. Rohan; Jeffrey B. Travers; Madelyn J. Hill; Arturo Aranda

doi:10.12659/AJCR.935898

20 June 2022 : Case report USA

Stellate Hypopigmentation in a Pediatric Patient After Treatment with Intralesionally-Injected Corticosteroid

Unusual clinical course, Challenging differential diagnosis, Unusual or unexpected effect of treatment, Diagnostic / therapeutic accidents, Rare disease, Adverse events of drug therapy

Janet E. Lubov^1ABCDEF, Craig A. Rohan^123ABCDEF, Jeffrey B. Travers^123ABCDEFG*, Madelyn J. Hill^4ABEF, Arturo Aranda^4ABDE

DOI: 10.12659/AJCR.935898

Am J Case Rep 2022; 23:e935898

Authors information Article notes Copyright and License information

Background Case Report Discussion Conclusions References:

Related articles Order reprints Share article Share by email

View HTML version

Figure 1. Keloid developed from the incision after gastrostomy tube placement in this Fitzpatrick type V pediatric patient.

Back to the Article

Stellate Hypopigmentation in a Pediatric Patient After Treatment with Intralesionally-Injected Corticosteroid

Your Privacy